Solventum Corporation (SOLV)
| Market Cap | 11.25B |
| Revenue (ttm) | 8.20B |
| Net Income (ttm) | 1.35B |
| Shares Out | 172.71M |
| EPS (ttm) | 7.79 |
| PE Ratio | 8.36 |
| Forward PE | 19.77 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,416,152 |
| Open | 65.00 |
| Previous Close | 65.15 |
| Day's Range | 64.70 - 66.23 |
| 52-Week Range | 60.72 - 72.40 |
| Beta | n/a |
| Analysts | Hold |
| Price Target | 69.50 (+6.69%) |
| Earnings Date | May 9, 2024 |
About SOLV
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a c... [Read more]
Financial Performance
In 2023, Solventum's revenue was $8.20 billion, an increase of 0.82% compared to the previous year's $8.13 billion. Earnings were $1.35 billion, an increase of 0.22%.
Financial numbers in USD Financial StatementsAnalyst Forecast
According to 3 analysts, the average rating for SOLV stock is "Hold." The 12-month stock price forecast is $69.5, which is an increase of 6.69% from the latest price.
News
Solventum Announces First Quarter 2024 Earnings Release Date and Upcoming Investor Events
ST. PAUL, Minn. , April 23, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that it will release carve-out financial results for the first quarter 2024 before the market opens on May 9, 20...
Solventum Names Shirley Edwards to Board of Directors
ST. PAUL, Minn. , April 15, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that its Board of Directors appointed Shirley Edwards, former partner, EY, to the board.
Solventum Stock Is Cheap. Why Wall Street Says to Wait.
The 3M healthcare spinoff picked up two new ratings this week.
I like Solventum's core business, but it isn't the cleanest of stories, says Jim Cramer
'Mad Money' host Jim Cramer takes a closer look at 3M spin-off company Solventum.
3M Completes Health Care Spinoff, and a Court Finalizes 'Forever Chemicals' Settlement
Two big announcements from 3M (MMM) sent shares of the conglomerate higher Monday.
3M Spinoff Solventum Stock Is Down 16%. What Happens Next.
The spinoff of 3M's healthcare business is complete and shares of the new company, called Solventum, are lower. It could be a buying opportunity.
3M healthcare spinoff Solventum slides on NYSE debut
Solventum Corp (NYSE: SOLV) lost about 3.0% as it debuted on the New York Stock Exchange on Monday. The healthcare name was separated from 3M & Co (NYSE: MMM) in March.
Solventum Begins Trading on the New York Stock Exchange
Formerly 3M Health Care Business, Solventum (NYSE: SOLV) enables better, smarter, safer healthcare to improve lives ST. PAUL, Minn.
GE Vernova and Solventum Set to Join S&P 500; Dentsply Sirona to Join S&P MidCap 400; Others to Join S&P SmallCap 600
NEW YORK , March 27, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600: Solventum Corp. (NYSE: SOLV) will be added to the S...
GE Vernova, Solventum to join S&P 500 index next week
Newly minted GE Vernova and Solventum Corp., both soon to be officially spun off from two industrial giants, are hitting it big early: They are joining the S&P 500 index next week.
These GE and 3M Spinoffs Are Set to Join the S&P 500
S&P Dow Jones Indices announced changes to its indexes as of the start of the second quarter.